[HTML][HTML] Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies
KS Kang, Y Wen, N Yamabe, M Fukui, SC Bishop… - PloS one, 2010 - journals.plos.org
Background A combination of levodopa (L-DOPA) and carbidopa is the most commonly-
used treatment for symptom management in Parkinson's disease. Studies have shown that …
used treatment for symptom management in Parkinson's disease. Studies have shown that …
[引用][C] Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies
KS Kang, Y Wen, N Yamabe, M Fukui… - PLoS …, 2010 - ui.adsabs.harvard.edu
Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and
Hippocampal Neurodegeneration: In Vitro and In Vivo Studies - NASA/ADS Now on home page …
Hippocampal Neurodegeneration: In Vitro and In Vivo Studies - NASA/ADS Now on home page …
[PDF][PDF] Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and
KS Kang, Y Wen, N Yamabe, M Fukui, SC Bishop - 2010 - researchgate.net
Background: A combination of levodopa (L-DOPA) and carbidopa is the most commonly-
used treatment for symptom management in Parkinson's disease. Studies have shown that …
used treatment for symptom management in Parkinson's disease. Studies have shown that …
Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: In vitro and in vivo studies.
KS Kang, Y Wen, N Yamabe, M Fukui, SC Bishop… - PLoS ONE, 2010 - psycnet.apa.org
Background: A combination of levodopa (L-DOPA) and carbidopa is the most commonly-
used treatment for symptom management in Parkinson's disease. Studies have shown that …
used treatment for symptom management in Parkinson's disease. Studies have shown that …
Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies
KS Kang, Y Wen, N Yamabe, M Fukui, SC Bishop… - PLoS ONE, 2010 - go.gale.com
Background A combination of levodopa (L-DOPA) and carbidopa is the most commonly-
used treatment for symptom management in Parkinson's disease. Studies have shown that …
used treatment for symptom management in Parkinson's disease. Studies have shown that …
[引用][C] Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies
KS Kang, Y Wen, N Yamabe, M Fukui, SC Bishop… - PLoS ONE, 2010 - cir.nii.ac.jp
Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and
Hippocampal Neurodegeneration: In Vitro and In Vivo Studies | CiNii Research CiNii 国立情報学 …
Hippocampal Neurodegeneration: In Vitro and In Vivo Studies | CiNii Research CiNii 国立情報学 …
[PDF][PDF] Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and
KS Kang, Y Wen, N Yamabe, M Fukui, SC Bishop - 2010 - pdfs.semanticscholar.org
Background: A combination of levodopa (L-DOPA) and carbidopa is the most commonly-
used treatment for symptom management in Parkinson's disease. Studies have shown that …
used treatment for symptom management in Parkinson's disease. Studies have shown that …
Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies.
KS Kang, Y Wen, N Yamabe, M Fukui… - PLoS …, 2010 - search.ebscohost.com
Background: A combination of levodopa (L-DOPA) and carbidopa is the most commonly-
used treatment for symptom management in Parkinson's disease. Studies have shown that …
used treatment for symptom management in Parkinson's disease. Studies have shown that …
[PDF][PDF] Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and
KS Kang, Y Wen, N Yamabe, M Fukui, SC Bishop - 2010 - scienceopen.com
Background: A combination of levodopa (L-DOPA) and carbidopa is the most commonly-
used treatment for symptom management in Parkinson's disease. Studies have shown that …
used treatment for symptom management in Parkinson's disease. Studies have shown that …
Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies.
KS Kang, YJ Wen, N Yamabe, M Fukui, SC Bishop… - 2010 - cabidigitallibrary.org
Background: A combination of levodopa (L-DOPA) and carbidopa is the most commonly-
used treatment for symptom management in Parkinson's disease. Studies have shown that …
used treatment for symptom management in Parkinson's disease. Studies have shown that …